1. Home
  2. FULC vs BMRC Comparison

FULC vs BMRC Comparison

Compare FULC & BMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • BMRC
  • Stock Information
  • Founded
  • FULC 2015
  • BMRC 1989
  • Country
  • FULC United States
  • BMRC United States
  • Employees
  • FULC N/A
  • BMRC N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • BMRC Major Banks
  • Sector
  • FULC Health Care
  • BMRC Finance
  • Exchange
  • FULC Nasdaq
  • BMRC Nasdaq
  • Market Cap
  • FULC 469.0M
  • BMRC 414.4M
  • IPO Year
  • FULC 2019
  • BMRC N/A
  • Fundamental
  • Price
  • FULC $7.87
  • BMRC $26.33
  • Analyst Decision
  • FULC Buy
  • BMRC Buy
  • Analyst Count
  • FULC 7
  • BMRC 4
  • Target Price
  • FULC $10.43
  • BMRC $28.00
  • AVG Volume (30 Days)
  • FULC 618.0K
  • BMRC 63.2K
  • Earning Date
  • FULC 10-29-2025
  • BMRC 10-27-2025
  • Dividend Yield
  • FULC N/A
  • BMRC 3.80%
  • EPS Growth
  • FULC N/A
  • BMRC N/A
  • EPS
  • FULC N/A
  • BMRC 0.62
  • Revenue
  • FULC N/A
  • BMRC $97,190,000.00
  • Revenue This Year
  • FULC N/A
  • BMRC $61.22
  • Revenue Next Year
  • FULC N/A
  • BMRC $12.24
  • P/E Ratio
  • FULC N/A
  • BMRC $42.54
  • Revenue Growth
  • FULC 2752.05
  • BMRC 63.71
  • 52 Week Low
  • FULC $2.32
  • BMRC $19.14
  • 52 Week High
  • FULC $10.11
  • BMRC $27.11
  • Technical
  • Relative Strength Index (RSI)
  • FULC 40.58
  • BMRC 65.15
  • Support Level
  • FULC $8.42
  • BMRC $25.45
  • Resistance Level
  • FULC $9.47
  • BMRC $26.37
  • Average True Range (ATR)
  • FULC 0.80
  • BMRC 0.64
  • MACD
  • FULC -0.21
  • BMRC 0.22
  • Stochastic Oscillator
  • FULC 7.11
  • BMRC 96.56

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About BMRC Bank of Marin Bancorp

Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.

Share on Social Networks: